Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Is there immune suppression in the critically ill patient - pro?
Kenneth E. Remy
,
Isaiah R. Turnbull
Institute of Clinical and Translational Sciences (ICTS)
Bursky Center for Human Immunology and Immunotherapy
Section of Acute and Critical Care Surgery
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Is there immune suppression in the critically ill patient - pro?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Sepsis
100%
Immune Suppression
100%
Critically Ill Patients
100%
Tumor Necrosis Factor-α
33%
Cytokine Levels
33%
Inflammatory Mediators
33%
Leukocytes
33%
Bone Marrow
33%
Lymphocyte Subsets
33%
Lymphocyte Apoptosis
33%
Monocytes
33%
Cytokine Production
33%
Immune System
33%
Shock-induced
33%
Immune Function
33%
Septic Patients
33%
Sepsis-induced Immunosuppression
33%
Increased Vulnerability
33%
Anergic
33%
Hyperinflammation
33%
Susceptibility to Infection
33%
Immune Status
33%
Immunomodulatory Therapy
33%
Endotoxic Shock
33%
Immunophenotyping
33%
New Human Leukocyte Antigen Allele
33%
Sepsis Therapy
33%
Classical Representation
33%
Neutrophil Dysfunction
33%
Monocytic Myeloid-derived Suppressor Cells (M-MDSCs)
33%
Immune-inflammatory Response
33%
Failed Clinical Trials
33%
Monocyte Dysfunction
33%
Immunology and Microbiology
Monocyte
100%
Cytokine
50%
Leukocyte
50%
Mediator
50%
Immunosuppression
50%
Immune Response
50%
Lymphocyte Subpopulation
50%
Immunosuppressive Drug
50%
Lymphocyte Apoptosis
50%
Infectious Disease
50%
Neutrophil
50%
Myeloid-Derived Suppressor Cell
50%
Human Leukocyte Antigen
50%
Tumor Necrosis Factor Alpha
50%
Cytokine Production
50%
Immune System
50%
Infection
50%
Susceptibility
50%